期刊文献+

环氧化酶-2及其抑制剂与头颈肿瘤细胞增殖和凋亡 被引量:1

原文传递
导出
摘要 有关环氧化酶-2(cyclooxygenase-2,COX-2)及其抑制剂在肿瘤中的作用机制研究已经相当广泛,对于其在头颈鳞状细胞癌中的研究也越来越深入,目前认为COX-2参与肿瘤发生的机制可能与多个环节有关。本文主要综述了COX-2及其抑制剂在头颈部鳞状细胞癌细胞增殖和凋亡中的作用机制,并对COX-2抑制剂抗肿瘤依赖和非依赖COX-2途径进行探讨。
出处 《国际耳鼻咽喉头颈外科杂志》 2008年第3期156-159,共4页 International Journal of Otolaryngology-Head and Neck Surgery
基金 四川省应用基础研究项目(05JY029-10L4)
关键词 环氧化酶-2 鳞状细胞 细胞增殖 细胞凋亡 Cyclooxygenase-2 Carcinoma, SquamousCell CellProliferation Apoptosis
  • 相关文献

参考文献20

  • 1Cornetta AJ, Russell JP, Cunnane M, et al. Cyclooxygenase-2 expression in human thyroid carcinoma and hashimoto' s thyroiditis. Laryngoscope, 2002, 112 (2) : 238-242.
  • 2邓刚,杨成章,陈望燕.环氧化酶-2与Ki-67在喉鳞状细胞癌中表达的特点及其临床意义[J].中国现代医学杂志,2005,15(17):2632-2635. 被引量:3
  • 3丁翔,严春寅,温端改,侯建全,浦金贤.COX-2、bcl-2和PCNA在前列腺癌中的表达及其意义[J].苏州大学学报(医学版),2005,25(1):110-112. 被引量:10
  • 4Hoozemans JJ, Bruckner MK, Rozemuller AJ, et al. Cyclin D1 and cyclinE are co-localized with cyclo-oxygenase2 (cox-2) in pyramidal neurons in Alzheimer disease temporal cortex. J Neuropathol Exp Neurol, 2002, 61 (8) : 678-688.
  • 5Subbaramaiah K, Altorki N, Chung WJ, et al. Inhibition of cyclooxygenase-2 gene expression by p53. J Biol Chem, 1999, 274 (16) : 10911-10915.
  • 6Kawabe A, ShimadaY, Uchida S, et al. Expression of cyclooxygenase-2 is associated with carcinogenesis of the lower part of thoracic esophageal squamous cell carcinoma and p53 expression. Oncology, 2002, 62 (1) 46-54.
  • 7Corcoran CA, He Q, Huang Y, et al. Cyclooxygenase-2 interacts with p53 and interferes with p53-dependent transcription and apoptosis. Oncology, 2005, 24 (9) : 1634-1640.
  • 8Gallo O, Schiavone N, Papucci L, et al. Down-regulation of nitric oxide synthase-2 and cyclooxygenase-2 pathway by p53 in squmous cell carcinoma. Am J Pathol, 2003, 163 (2) : 723-732.
  • 9陈福春,张玉霞,陈洪雷,李红钢,陶鸿潮,杨飞,夏东,刘铭球.大鼠肺鳞癌发生发展中环氧化酶-2和caspase-3的表达和意义[J].肿瘤防治杂志,2004,11(10):1009-1013. 被引量:4
  • 10周乐源,周菊英,吴玉玉.鼻咽癌组织中COX-2与Survivin表达的关系及临床意义[J].苏州大学学报(医学版),2006,26(1):95-97. 被引量:8

二级参考文献33

  • 1谢红付,赫尔米,冯浩.环氧化酶-2在尖锐湿疣中的表达及与细胞增殖的关系[J].中国现代医学杂志,2004,14(22):104-105. 被引量:2
  • 2孙娜,葛荣明.VEGF和iNOS在喉鳞状细胞癌中的表达及临床意义[J].临床耳鼻咽喉科杂志,2004,18(12):723-726. 被引量:6
  • 3Kirschenbaum A, Klausner AP, Lee R, et al. Expression of Cyclooxygenase-1 and Cyclooxygenase-2 in the human prostate[ J ]. Urology, 2000, 56: 671 - 676.
  • 4Zha S, Gage WR, Jsauvageot J, et al. Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma [ J ] . Cancer Res,2001,61: 8617 - 8623.
  • 5Subbarayan V, Sabichi AL, Llansa N, et al. Differential expression of cyclooxygenase-2 and its regulation by tumor necrosis factor-alpha in normal and malignant prostate cells[J]. Cancer Res, 2001,61:2720 - 2726.
  • 6Madaan S, Abel PD, Chaudhary KS, et al. Cytoplasmic induction and overexpression of cyclooxygenase-2 in human prostate cancer: implications for prevention and treatment[J]. BJU Int, 2000, 86:736 - 741.
  • 7Lee LM, Pan C C, Cheng C J, et al. Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia [J ]. Anticancer Res, 2001, 21 :1291 - 1294.
  • 8Tanji T, Kikigawa T, Yokoyama M, et al. Immunohistochemistry study of cyclooxygenases in prostatic adenocarcinoma: relationship to apoptosis and bcl-2 protein expression[J]. Anticancer Res, 2000, 20: 2313 - 2320.
  • 9Hussain T, Gupta S, Mukhtar H, Cy-clooxygenase-2 and prostate carcinogenesis [ J ]. Cancer Letters, 2003, 191:125 - 135.
  • 10Chaudhary K S, Abel P D, Lalani E N, Role of the Bcl-2gene family in prostate cancer progression and its implications for therapeutic intervention[J]. Environ Health Perspect, 1999, 107: 49 - 57.

共引文献21

同被引文献29

  • 1Yuan Y,Hunt RH.Global gastrointestinal safety profile of etoricoxib and lumiracoxib.Curr Pharm Des,2007,13 (22):2237-2247.
  • 2Takatori H,Natsugoe S,Okumura H,et al.Cyclooxygenase-2 expression is related to prognosis in patients with esophageal squamous cell carcinoma.Eur J Surg Oncol,2008,34 (4):397-402.
  • 3Kurihara Y,Hatori M,Ando Y,et al.Inhibition of cyclooxygenase-2 suppresses the invasiveness of oral squamous cell carcinoma cell lines via down-regulation of matrix metalloproteinase-2 production and activation.Clin Exp Metastasis,2009,26 (5):425-432.
  • 4Schetter AJ,Heegaard NH,Harris CC.Inflammation and cancer:interweaving microRNA,free radical,cytokine and p53 pathways.Carcinogenesis,2010,31 (1):37-49.
  • 5Oyama K,Fujimura T,Ninomiya I,et al.Cyclooxygenase (COX) -2 expression in a rat duodenoesophageal reflux model and chemoprevention of adenocarcinoma by the selective COX-2 inhibitor nimesulide.Nippon Shokakibyo Gakkai Zasshi,2007,104 (8):1183-1191.
  • 6Yamamoto K,Kitayama W,Denda A,et al.Expression of receptor for advanced glycation end products during rat tongue carcinogenesis by 4-nitroquinoline 1-oxide and effect of a selective cyclooxygenase-2 inhibitor,etodolac.Pathobiology,2006,73(6):317-324.
  • 7Terakado N,Shintani S,Yano J,et al.Overexpression of cyclooxygenase-2 is associated with radioresistanee in oral squamous cell carcinoma.Oral Oncol,2004,40 (4):383-389.
  • 8Chen WC,McBride WH,Chen SM,et al.Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy:clinical and in vitro studies.Head Neck,2005,27 (6):503-512.
  • 9Louw L,Claassen J.Rationale for adjuvant fatty acid therapy to prevent radiotherapy failure and tumor recurrence during early laryngeal squamous cell carcinoma.Prostaglandins Leukot Essent FattyAcids,2008,78 (1):21-26.
  • 10Czembirek C,Eder-Czembirek C,Erovic BM,et al.The cyclooxygenase-2 inhibitor nimesulide,a nonsteroidal analgesic,decreases the effect of radiation therapy in head-and-neck cancer cells.Strahlenther Onkol,2009,185 (5):310-317.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部